Pushkal Garg
EVP Chief R&D at Alnylam Pharmaceuticals · 64 reported transactions in 1 company · latest trade Feb 27, 2026
Their trades
Sold | Feb 27, 2026 | Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days. | ||
Sold | Feb 27, 2026 | Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days. | ||
Sold | Feb 27, 2026 | Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days. | ||
Sold | Feb 27, 2026 | Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days. | ||
Sold | Feb 27, 2026 | Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days. | ||
Sold | Feb 13, 2026 | Feb 13, 2026 close $314.40 → Oct 26, 2026 close $227.66. S&P 500 +12.3% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. |
$46.8K
Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days.
$313.2K
Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days.
$384.2K
Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days.
$747.1K
Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days.
$41.8K
Feb 27, 2026 close $332.92 → Oct 26, 2026 close $227.66. S&P 500 +11.6% over the same days.
$695.2K
Feb 13, 2026 close $314.40 → Oct 26, 2026 close $227.66. S&P 500 +12.3% over the same days.
$5.7K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$7.1K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.